Tanke Biosciences Corporation Sustainability Profile
Tanke Biosciences Corporation, a leading innovator in the biotechnology sector, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced biopharmaceuticals and cutting-edge diagnostic solutions. With a focus on harnessing the power of synthetic biology, Tanke Biosciences offers unique products that address critical health challenges. The company operates primarily in North America and has expanded its reach into Europe and Asia, showcasing its commitment to global health advancements. Tanke's core offerings include proprietary gene editing technologies and tailored therapeutic solutions, which distinguish it from competitors in the market. Recognised for its scientific excellence, Tanke Biosciences continues to push the boundaries of innovation, contributing significantly to the future of healthcare.
DitchCarbon Score
How does Tanke Biosciences Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tanke Biosciences Corporation's score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tanke Biosciences Corporation's reported carbon emissions
Tanke Biosciences Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Tanke Biosciences may still be in the early stages of developing its climate strategy or reporting framework. In the context of the industry, many companies are increasingly adopting science-based targets and committing to significant reductions in greenhouse gas emissions. However, without specific commitments or emissions data, it is challenging to assess Tanke Biosciences' position relative to its peers in the biosciences sector. As the company progresses, it may consider aligning with industry standards and frameworks to enhance its climate commitments and transparency.
How Carbon Intensive is Tanke Biosciences Corporation's Industry?
How Carbon Intensive is Tanke Biosciences Corporation's Location?
Tanke Biosciences Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tanke Biosciences Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Changsha Xingjia Biological Technology Co., Ltd.
MERCK Kommanditgesellschaft auf Aktien
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.